Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that Peter D. Suzdak, PhD, the Company’s Chief Executive Officer, and Ted Jeong, Chief Financial Officer will participate in the Brean Capital 2013 Life Sciences Summit. The life sciences-focused one day conference will feature small group sessions and one-on-one meetings. It is being held on November 25, 2013 at Convene located at 730 Third Avenue, New York City.
Help employers find you! Check out all the jobs and post your resume.
